Acquiring Company
Northwest Biotherapeutics
Acquired Company
Advent BioServices Ltd
Bethesda
LondonBiotechnologyHealthcareresearchManufacturingBiotechnologyDescription
Northwest Biotherapeutics has successfully closed its acquisition of Advent BioServices Ltd., making Advent a wholly owned subsidiary. This strategic move is expected to enhance operational efficiencies and scale-up capabilities for NWBio. The acquisition includes significant assets and intellectual property previously held by Advent. Payments for the acquisition will be structured over two years.
Other recent acquisitions in Healthcare and research
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- SAI Parenterals acquires majority stake in Noumed (December 5, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- Harrow acquires Melt Pharmaceuticals for sedation solutions (November 18, 2025)
- Merck Sharp & Dohme LLC to Acquire Cidara Therapeutics, Inc. (November 13, 2025)
- Galecto, Inc. Acquires Damora Therapeutics, Inc. (November 10, 2025)
- IBA acquires PhantomX to enhance AI quality assurance (November 3, 2025)
Who to call at Northwest Biotherapeutics, and when
When Northwest Biotherapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Northwest Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Northwest Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Northwest Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Northwest Biotherapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Advent BioServices Ltd?
Advent BioServices Ltd was acquired by Northwest Biotherapeutics, based in Bethesda. The deal was reported on October 24, 2025. Northwest Biotherapeutics is publicly traded (NWBO) and operates in Biotechnology.
When did Northwest Biotherapeutics acquire Advent BioServices Ltd?
Northwest Biotherapeutics's acquisition of Advent BioServices Ltd was reported on October 24, 2025. Northwest Biotherapeutics has successfully closed its acquisition of Advent BioServices Ltd., making Advent a wholly owned subsidiary. This strategic move is expected to enhance operational efficiencies and scale-up capabilities for NWBio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Advent BioServices Ltd do?
Advent BioServices Ltd. is involved in providing contract services in bio-manufacturing and clinical development. They have extensive facilities and capabilities for GMP-compliant production processes. It is privately held, operating in Manufacturing, and is based in London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.